ArticleFrontiers in oncology2021

Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer.

Yizhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.